| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68be76dd063e3301487afa70ea3f2975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0a65f1753e8c15d6663127d0c828dac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4d6a1a6aad1911c43ecf0dc49eb0ecb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3b0fc18f9071e403778b0a51a1cd7b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03942ca17769436e7ed365626838066f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 |
| filingDate |
2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daf5cdbbff3907c1fa04c620c72f7b14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9f67d01bb38df001849c058ed232c66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27d4d6d5dd86b8a9ae6df3d6cfea929a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16a0c8b2ac5e6632281b49431f7aae63 |
| publicationDate |
2007-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007079389-A2 |
| titleOfInvention |
Composition and method of use thereof |
| abstract |
A pharmaceutical composition comprises (a) metronidazole in an antibacterially effective amount; and (b) an antifungal agent in an antifungally effective amount, illustratively comprising butoconazole or a pharmaceutically acceptable salt or ester thereof. The composition is adapted for application in a unit dose amount to a vulvovaginal surface and has at least one nonlipoidal internal phase and at least one lipoidal external phase that is bioadhesive to the vulvovaginal surface. The composition is useful for administration to a vulvovaginal surface to treat a mixed bacterial vaginosis and vulvovaginal candidiasis infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-021943-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8946276-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019183859-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9198858-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010079373-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013005785-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10596155-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020201378-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3094636-A1 |
| priorityDate |
2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |